YARROW BIOSCIENCE, INC. Cash and Restricted Cash
YARROW BIOSCIENCE, INC. (YARW) had Cash and Restricted Cash of $22.93 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.93M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.63M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.03M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.05M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $22.93M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $24.63M S-4/A · filed 2026-06-03 |
| 2025-12-31 | $24.03M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $22.05M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $28.21M S-4/A · filed 2026-06-03 |
| 2024-12-31 | $19.93M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $16.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $29.66M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $19.12M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $30.67M S-4/A · filed 2026-06-03 |
| 2023-09-30 | $15.50M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $20.70M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $30.28M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $30.98M 10-K · filed 2025-03-06 |
| 2022-09-30 | $35.58M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $42.81M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $51.10M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $42.85M 10-K · filed 2024-03-01 |
| 2021-09-30 | $52.91M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $104.01M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $119.37M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $58.42M 10-K · filed 2023-03-14 |
| 2020-09-30 | $73.81M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $97.37M 10-Q · filed 2021-08-12 |
| 2020-03-31 | $58.46M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $44.58M 10-K · filed 2022-03-17 |
| 2019-09-30 | $40.78M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $39.34M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $19.24M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $28.12M 10-K · filed 2021-03-04 |
| 2017-12-31 | $16.21M 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |